eShowcase: LabPas CT 2.5
Phase I package adds formulary accountability, recruitment, lab, and EDC features
Phase I package adds formulary accountability, recruitment, lab, and EDC features
LabPas CT 2.5
Green Mountain Logic (Montpellier, VT) has added formulary accountability, recruitment, clinical lab, and EDC components to LabPas CT, its software package designed for Phase I management. LabPas CT 2.5 deploys PDAs on clinic floors for scanning patient and collection vessel barcodes and RFIDs to eliminate error potential. It provides real-time electronic data entry for collection times, comments, dosing, vital signs, and adverse events, and can adapt to changing protocols.
Enhancements in the latest version of LabPas CT allow users to track and manage the entire fomulary chain including accountability, distribution, reconciliation, returns, and destruction. The package also allows users to manage subject information such as biometrics, and handles scheduling and study assignment tasks. Also, the new clinical lab component of LabPas CT integrates clinical trial results into the study database, and the software exports clinical study data in a variety of formats for easy eCRF creation.
Green Mountain Logic, (866) LABPAS1,
Articles in this issue
almost 19 years ago
Impact of EU Directive on Clinical Developmentalmost 19 years ago
Assessing Safety in Clinical Trialsalmost 19 years ago
eShowcase: eCTDXPress Aspirealmost 19 years ago
Informed Consent Considerationsalmost 19 years ago
eShowcase: GlobalView EventNetalmost 19 years ago
Subject Protection Issues Gain Broad Supportalmost 19 years ago
Data Management: R.I.P. or Brave New World?almost 19 years ago
Hurricane Katrina: What Have We Learned?almost 19 years ago
Broad Introduction to CTsalmost 19 years ago
CDISC Standards Energize EDCNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Operational Challenges of Using Overall Survival as a Primary Endpoint
September 22nd 2025
- Strategic Participant Payments for Twenty-First Century Clinical Trials
September 19th 2025